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Abstract
 
It has been shown that certain pathogens can trigger efficient T cell responses in the absence of
CD28, a key costimulatory receptor expressed on resting T cells. Inducible costimulator pro-
tein (ICOS) is an inducible costimulator structurally and functionally related to CD28. Here,
we show that in the absence of CD28 both T helper cell type 1 (Th1) and Th2 responses were
impaired but not abrogated after infection with lymphocytic choriomeningitis virus (LCMV),
 
vesicular stomatitis virus (VSV), and the nematode 
 
Nippostrongylus brasiliensis
 
. Inhibition of
ICOS in CD28-deficient mice further reduced Th1/Th2 polarization. Blocking of ICOS
alone had a limited but significant capacity to downregulate Th subset development. In con-
trast, cytotoxic T lymphocyte (CTL) responses, which are regulated to a minor and major ex-
tent by CD28 after LCMV and VSV infection, respectively, remained unaffected by blocking
ICOS. Together, our results demonstrate that ICOS regulates both CD28-dependent and
 
CD28-independent CD4
 
1
 
 subset (Th1 and Th2) responses but not CTL responses in vivo.
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Introduction
 
Efficient induction of T cell responses requires antigen-spe-
cific triggering of TCRs together with the engagement of
costimulatory molecules such as CD28 and accessory mole-
cules such as LFA-1 and CD2. Although the generation of
T cell responses against most model antigens requires
CD28-mediated costimulation, many pathogens, including
 
lymphocytic choriomeningitis virus (LCMV)
 
1
 
 (1), vaccinia
virus (2),
 
 Heligmosomoides polygyrus
 
 (3), and 
 
Leishmania major
 
(4), have been shown to trigger efficient T cell responses in
CD28-deficient mice. Various factors may contribute to
these CD28-independent T cell responses. Activation of
the innate immune system by pathogen-associated molecu-
lar components can augment T cell responses by activation
of APCs via pattern recognition receptors, which may re-
sult in enhanced antigen processing and presentation, cy-
tokine production, and extended T cell stimulation due to
 
prolonged APC survival (5, 6). In addition, a variety of
accessory receptors other than CD28 can stimulate specific
 
T cell responses, including heat-stable antigen (HSA [7]),
4-1BB (8), and OX40 (9). Extended T cell stimulation by
pathogens due to slow antigen clearance has also been
shown to regulate the magnitude of CD28-independent
CTL responses (2). Thus, activation of APCs, the presence
of alternative costimulation pathways, and duration of T
cell stimulation may all contribute to CD28-independent T
cell responses after infection.
Inducible costimulator protein (ICOS), a surface recep-
tor expressed on activated T cells, is a good candidate for
such a CD28-independent pathway of T cell activation,
since it is a close homologue of CD28 and does not interact
with B7-1 and B7-2 (10). Cross-linking of ICOS together
with CD3/TCR has been shown to augment the produc-
tion of Th1 and Th2 cytokines with the exception of IL-2
(10, 11). More recently, murine ICOS has also been cloned
by subtractive hybridization PCR analysis of Th1 versus
Th2 effector cells, since it was specifically expressed by Th2
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Abbreviations used in this paper:
 
 BAL, bronchoalveolar lavage; ICOS,
inducible costimulator protein; LCMV, lymphocytic choriomeningitis vi-
 
rus; RANK, receptor activator of nuclear factor 
 
k
 
B; VSV, vesicular sto-
matitis virus. 
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cells (Coyle, A.J., and J.-C. Gutierrez-Ramos, manuscript
submitted for publication).
To assess the role of ICOS in T cell activation in vivo,
we studied the generation of parasite-induced Th2 and vi-
rus-induced Th1 and CTL responses in the absence of
functional ICOS and/or CD28. Our results indicate that
both ICOS- and CD28-mediated signaling contribute to
CD4
 
1
 
 effector responses against parasite and viral antigens,
although the relative requirement for these receptors de-
pends on the nature of the immune response. In contrast,
ICOS did not play a significant role in the induction of a
CTL response.
 
Materials and Methods
 
Mice and Pathogens.
 
BALB/c and C57BL/6 mice were pro-
vided by IFFA-Credo. CD28
 
2
 
/
 
2
 
 mice (1; provided by T.W.
Mak, University of Toronto, Toronto, Ontario, Canada) were
backcrossed for more than six generations to both C57BL/6 and
BALB/c mice, and maintained in a facility free of specific patho-
gens at the Basel Institute for Immunology. The LCMV isolate
WE was grown on L cells at a low multiplicity of infection.
LCMV (200 PFU/mouse) was injected into the left footpad. Ve-
sicular stomatitis virus (VSV) serotype Indiana (obtained from P.
Ohashi, University of Toronto, Toronto, Ontario, Canada) was
grown on BHK cells at a low multiplicity of infection. Mice were
infected intravenously with 2 
 
3 
 
10
 
6
 
 PFU. The life cycle of the
nematode 
 
Nippostrongylus brasiliensis
 
 was maintained by passage in
Tif Rai rats. Mice were infected subcutaneously with 750 third
stage infective larvae (L3).
 
Generation of ICOS-Ig.
 
Murine ICOS has been cloned by
subtractive hybridization PCR of Th1 and Th2 cells (Coyle, A.J.,
and J.-C. Gutierrez-Ramos, manuscript submitted for publica-
tion). The DNA sequence encoding the extracellular part of mu-
rine ICOS was amplified by PCR and cloned into an expression
vector containing the CD5 signal sequence and the human IgG1
constant region (Fc). Sequencing of the resulting construct con-
firmed in-frame ICOS coding region and the absence of a muta-
tion. Subsequently, COS cells were transiently transfected with
the plasmid using lipofectamine (GIBCO BRL). The produced
ICOS-Ig fusion molecule was purified using a protein A column.
SDS-PAGE analysis demonstrated a purity 
 
.
 
90%. Human IgG1
(Sigma-Aldrich) was used as control in all experiments.
 
Bronchoalveolar Lavage. N. brasiliensis
 
–infected mice were
killed by CO
 
2
 
 7 d after infection, and the tracheae were cannu-
lated with a 22-G needle surrounded by a plastic tubing (Polyeth-
ylene [PE] 60 Intramedic Tubing; Becton Dickinson). PBS (0.3
ml) was injected and withdrawn repeatedly (four times) with a
syringe. Bronchoalveolar lavage (BAL) cells were harvested and
used for flow cytometry analysis.
 
Expression of Intracellular Cytokines.
 
To analyze intracellular
cytokine expression, cells were stimulated with PMA (10
 
2
 
7 
 
M)
and ionomycin (1 
 
m
 
g/ml) for 4 h. 2 h before harvesting, brefeldin
A (10 
 
m
 
g/ml) was added to cultures to retain cytokines in the cy-
toplasm. Subsequently, cells were incubated with anti-CD32 to
block Fc binding followed by staining with allophycocyanin-
labeled anti-CD4 and FITC-labeled anti-CD8 antibodies for 15
min at 4
 
8
 
C. Subsequently, cells were washed once with PBS,
then fixed with 2% paraformaldehyde for 30 min at room tem-
perature followed by intracellular staining in permeabilization
buffer containing 0.5% saponin, 1% BSA in PBS, and either PE-
 
labeled anti–IL-4, PE-labeled anti–IL-10, or PE-labeled anti–
IFN-
 
g
 
 antibodies (all from BD PharMingen). Cells were washed
and resuspended in 1% BSA/PBS solution and analyzed by flow
cytometry. Data were analyzed using CellQUEST™ software
(Becton Dickinson).
 
Proliferation and Cytokine Production of Virus-specific CD4
 
1
 
 T
Cells.
 
Mice were killed at day 12 after LCMV infection, or at
day 6 after VSV infection. Spleens were removed, and subse-
quently CD4
 
1
 
 T cells were purified by MACS
 
®
 
 according to the
instructions of the supplier (Miltenyi Biotec). Purity was 
 
.
 
95%.
CD4
 
1
 
 T cells (10
 
5
 
) were stimulated with irradiated splenocytes
(10
 
5
 
) pulsed with LCMV (highest concentration
 
 5 
 
multiplicity of
infection
 
 5 
 
0.3) or UV light–inactivated VSV (highest concen-
trations
 
 5 
 
3
 
 3 
 
10
 
7
 
 PFU/ml). After 4 d, an aliquot of the superna-
tant was removed for measurement of IFN-
 
g
 
 levels, and prolifer-
ation was assessed by [
 
3
 
H]thymidine incorporation.
 
Footpad Swelling and Measurement of CTL Responses.
 
Mice
were immunized with LCMV (200 PFU) into one footpad, and
footpad size was assessed daily using a spring-loaded caliper. 12 d
after infection, spleen cell suspensions were prepared and tested
directly in a 
 
51
 
Cr-release assay, essentially as described (12) using
peptide p33 (derived from the LCMV glycoprotein, amino acids
33–42) labeled EL-4 cells as target cells. In brief, EL-4 target cells
were pulsed with peptide p33 (KAVYNFATM, amino acids 33–
42 derived from the LCMV glycoprotein) at a concentration of
10
 
2
 
7
 
 M for 90 min at 37
 
8
 
C in the presence of [
 
51
 
Cr]sodium chro-
Figure 1. ICOS and CD28 contribute to nematode-induced Th1 and
Th2 cytokine production in draining lymph node cells. CD282/2 and
BALB/c control mice (n 5 8/group) were infected subcutaneously with
N. brasiliensis (750 larvae L3) and treated intravenously with 100 mg
ICOS-Ig (n 5 4) or control IgG1 (n 5 4) at days 0, 2, 4, and 6. At day 7,
mice were killed and mesenteric lymph node cells were isolated and
stimulated in pools at a density of 5 3 105/microwell with specific anti-
gen (N. brasiliensis protein extract, 75 mg/well) for 4 d. Levels of IL-4,
IL-5, IL-10, and IFN-g in the supernatants were measured by ELISA us-
ing paired mAbs (BD PharMingen). Data are representative of two sepa-
rate experiments. 
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Results
 
ICOS Mediates CD28-independent Priming of Th2 Cells.
 
Infection with the gastrointestinal nematode 
 
N
 
.
 
 brasiliensis 
 
is
a well-characterized model used to study Th2 responses
(15). Clearance of worms is critically dependent on the IL-
4/IL-13 pathway (16–18). Reduced Th2 responses have
been reported in 
 
N
 
.
 
 brasiliensis
 
–infected mice treated with
CTLA-4-Ig, whereas Th2 responses were completely nor-
mal in CD28-deficient mice infected with 
 
H
 
.
 
 polygyrus
 
, an-
other gastrointestinal nematode (3). To study the role of
ICOS for the generation of Th subset responses in the pres-
ence and absence of CD28, both wild-type BALB/c and
CD28-deficient (BALB/c) mice were infected with third
stage (L3) larvae of 
 
N
 
.
 
 brasiliensis
 
 and were additionally treated
with an ICOS-Ig fusion molecule or control human IgG1
antibodies. Mesenteric lymph node cells were isolated at day
7 and restimulated in vitro with a protein extract derived
from mature worms to measure cytokine production. As
expected, BALB/c mice produced the Th2 cytokines IL-4,
IL-5, and IL-10, and also the Th1 cytokine IFN-
 
g
 
. Inhibi-
tion of ICOS in BALB/c mice resulted in reduced Th2 and
Th1 cytokine production (Fig. 1). In the absence of CD28,
levels of IL-4, IL-5, IL-10, and IFN-
 
g
 
 were either absent or
strongly reduced (Fig. 1). Therefore, no conclusion could be
reached as to the potential of ICOS to mediate CD28-inde-
pendent T cell responses. Nevertheless, these results indicate
that both ICOS and CD28 promote the generation of Th2
and Th1 responses to nematode-specific antigens.
After penetration (or infection) through the skin during
the first 2 d, L3 larvae migrate to the lungs, where a strong
eosinophilic inflammatory response is induced (19). From
there, the larvae reach the esophagus and finally the intes-
Figure 2. Inhibition of ICOS reduces the fre-
quency of pulmonary Th1 and Th2 cells but not
CD81 IFN-g1 T cells in CD282/2 mice. Mice
(n 5 4/group) were infected with N. brasiliensis and
treated as described in the legend to Fig. 1. At day
7, BAL was performed and BAL cells were stimu-
lated with PMA and ionomycin for 4 h in the pres-
ence of brefeldin A for the last 2 h to retain cyto-
kines in the cytoplasm. Cells were stained with
allophycocyanin-labeled anti-CD4 and FITC-labeled
anti-CD8, followed by fixation, permeabilization,
and intracellular staining with PE-labeled IL-4, PE-
labeled anti–IL-10, or PE-labeled anti–IFN-g. Sub-
sequently, cells were analyzed by three-color flow
cytometry. Values indicate percentage of CD41 T
cells expressing IL-4, IFN-g, and IL-10, and CD81
T cells expressing IFN-g of BAL from individual
mice. Shown in brackets are averages of groups of
mice. Data are representative of three separate ex-
periments.
 
mate in IMDM supplemented with 10% FCS. Ex vivo–isolated
spleen cell suspensions from infected mice were serially diluted
and mixed with peptide-pulsed target cells. 
 
51
 
Cr release was de-
termined after 5 h in a gamma counter.
Alternatively, mice were infected intravenously with 2 
 
3 
 
10
 
6
 
PFU VSV, and spleen cells were isolated 6 d later and tested in a
 
51
 
Cr-release assay on EL-4 cells pulsed with peptide NP derived
from VSV nucleoprotein (12).
 
Generation and Use of Tetramers.
 
Soluble, biotinylated class I
monomers, comprising the murine D
 
b
 
 molecule, human 
 
b
 
2-
microglobulin, and LCMV peptide p33, were generated as de-
scribed previously (13). Tetramer complexes were subsequently
generated by stepwise addition of PE-labeled extravidin (Sigma-
Aldrich) to the biotinylated monomers at a 1:4 molar ratio.
 
 
 
Single
cell suspensions were prepared from spleens and incubated with
PE-conjugated tetramers at 37
 
8
 
C for 15 min. Allophycocyanin-
conjugated anti-CD8 antibodies were then added on ice for 30
min. Cells were washed and analyzed on a FACScan™ (Becton
Dickinson) using CellQUEST™ software.
 
Detection of Antibodies by ELISA.
 
Antibodies against the NP
of LCMV were detected by an ELISA. Recombinant NP ex-
pressed by baculovirus (14; a gift from Rolf Zinkernagel (Institute
of Experimental Immunology, Zürich, Switzerland), was coated
onto a 96-well plate (Maxisorp; Nunc) in a concentration of 200
ng/well in 50 
 
m
 
l PBS overnight at 4
 
8
 
C. Subsequent steps were
performed at room temperature and followed by three washing
procedures with PBS. Coated plates were blocked with 1% BSA
for 1–2 h, and sera serially diluted in PBS containing 0.1% BSA
were then added for 3–5 h. Alkaline phosphatase–labeled goat
anti–mouse antibodies to IgG1, IgG2a, or IgG2b (Southern Bio-
technology Associates, Inc.) were added for 1–2 h followed by
the addition of 
 
p
 
-nitrophenyl phosphate (Sigma-Aldrich) as sub-
strate before reading the OD at 405 nm. Positive titers were de-
fined as three standard deviations above mean values of negative
controls. 
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tines, where they mature into egg-laying adults (at days
5–8). To measure Th subset development more directly in
vivo, we performed a BAL at day 7, and studied CD4
 
1
 
 and
CD8
 
1
 
 T cell cytokine production at the single cell level by
intracellular staining and flow cytometry. Blocking of
ICOS in BALB/c mice reduced the frequency of pulmo-
nary Th1 cells (IFN-
 
g
 
1
 
 CD41 cells) by z50%, whereas the
frequency of Th2 cells (IL-41 and IL-101) was reduced by
only 20–25% (Fig. 2). Absence of CD28 had more of an ef-
fect, since the number of both Th1 and Th2 cells was re-
duced by 50–75% (Fig. 2). Importantly, residual Th1 and
Th2 cells in CD28-deficient mice were further reduced
upon inhibition of ICOS. The frequency of IFN-g–pro-
ducing CD81 T cells was reduced by 35% in CD28-defi-
cient mice compared with wild-type BALB/c mice. In
contrast, inhibition of ICOS did not show an effect on
CD81 T cells in either wild-type BALB/c or CD28-defi-
cient mice (Fig. 2). Together, our results demonstrate that
CD28 is the main costimulator of Th1/Th2 polarization to
nematode infection with a limited but significant role of
ICOS. However, ICOS mediated CD28-independent Th
responses, indicating functionally redundant pathways. Im-
portantly, CD28- and ICOS-mediated signals augmented
not only Th2 but also Th1 responses to N. brasiliensis.
ICOS Costimulates Antiviral Th1 Responses. LCMV in-
duces a strong Th1 response in mice (20). To assess the role
of ICOS in costimulating Th1 responses, groups of CD28-
deficient and C57BL/6 control mice were infected with
LCMV and treated with the ICOS-Fc fusion molecule or
control human IgG1. 12 d after infection, splenocytes were
isolated and purified CD41 T cells were stimulated in vitro
with LCMV-infected APCs. Proliferation (Fig. 3 A) and
IFN-g production (Fig. 3 B) of LCMV-specific CD41 T
cells derived from CD28-deficient mice were strongly re-
duced. Nevertheless, remaining CD41 T cell responses to
LCMV in the absence of CD28 were significant (Fig. 3, A
and B). Neutralization of ICOS abrogated proliferation and
IFN-g secretion in CD28-deficient mice (Fig. 3, A and B),
whereas it did not significantly inhibit the generation of
Th1 responses in wild-type C57BL/6 mice. Thus, ICOS
mediates the residual CD28-independent component of
the LCMV-specific Th1 response.
Next, we wanted to assess the roles of ICOS and CD28
for the stimulation of CD41 T cells during a less virulent
infection than LCMV. To this end, we used VSV, which
replicates only abortively in mice, and infected C57BL/6
and CD28-deficient mice treated repeatedly with ICOS-Fc
or control human (h)IgG1. Splenic CD41 T cells were pu-
rified on day 6 after infection and restimulated in vitro us-
ing splenic APCs pulsed with UV light–inactivated virus
particles. As previously shown for the VSV-specific CTL
response (2), CD28-deficient mice failed to mount a mea-
surable proliferative CD41 T cell response to VSV (Fig. 3
C). In addition, inhibition of ICOS triggering in C57BL/6
mice substantially inhibited the proliferation of VSV-spe-
cific CD41 T cells (Fig. 3 C), indicating that ICOS may be
involved in the costimulation of weak (VSV) but not
strong (LCMV) Th1 responses.
ICOS has been reported to be expressed by germinal
center T cells (10). Therefore, it was conceivable that it is
critically involved in the regulation of Th cell–dependent B
cell responses. To assess this question, we measured specific
IgG antibody levels in response to LCMV infection in the
various groups of mice. IgG1, IgG2a, and IgG2b antibody
responses were reduced 5–10-fold in CD28-deficient mice,
but were not affected in C57BL/6 mice treated with
ICOS-Fc (Fig. 4). Surprisingly, neutralization of ICOS in
CD28-deficient mice did not further reduce specific anti-
body levels (Fig. 4), despite reduced CD41 T cell prolifera-
tion and IFN-g production in this situation.
Blocking ICOS Does Not Affect Antiviral CTL Responses.
It has been reported that LCMV induces an efficient CTL
response in the absence of CD28 (1, 2). Therefore, the role
Figure 3. ICOS costimulates antiviral Th1 responses. CD282/2 mice
(open symbols) and C57BL/6 control mice (BL/6, filled symbols) were
infected with LCMV (200 PFU) into the footpad (A and B) or with VSV
intravenously (C). Groups of mice (n 5 4) were injected intraperitoneally
with ICOS-Ig (circles) or control IgG1 (squares) starting at day 0 every 2 d
until day 10 (A and B) or until day 4 (C). CD41 T cells were isolated at
day 12 (A and B) or at day 6 (C) and restimulated with splenic APCs
pulsed with viral particles. Proliferation (A and C) and secretion of IFN-g
(B) were assessed 4 d after stimulation. Data are representative of two sep-
arate experiments.57 Kopf et al.
of ICOS in the regulation of CTL responses against
LCMV was assessed next. C57BL/6 and CD28-deficient
mice were infected locally in the footpads with LCMV and
treated repeatedly every 2 d with ICOS-Fc or control
hIgG1. LCMV induces an immunopathological footpad
swelling reaction upon local injection of live virus (21).
This swelling reaction is mediated exclusively by CD81 T
cells in the early phase of an immune response, and there-
fore serves as an excellent in vivo read-out for CTL activity
(22). LCMV-induced footpad swelling reaction was clearly
impaired in the CD28-deficient mice. However, blocking
ICOS showed no effect on footpad size in either control or
CD28-deficient mice, indicating that it was not signifi-
cantly involved in the induction of this CD81 T cell–
mediated immunopathology (Fig. 5 A). In agreement with
these results, the lytic activity of LCMV-specific CTLs, as
determined by classical 51Cr-release assay, was slightly re-
duced in CD28-deficient mice, but remained unaffected in
control and CD28-deficient mice treated with ICOS-Fc
(Fig. 5 B). To directly assess the frequency of LCMV-spe-
cific CTLs by flow cytometry, we stained spleen cells from
infected mice with CD8 and MHC class I tetramers loaded
with specific peptide (13). Consistent with the lytic activ-
ity, CD28-deficient mice showed a frequency of specific
CD81 T cells that was reduced by z25% compared with
control mice, whereas ICOS in the presence and absence
of CD28 appeared to play no significant role in the reg-
ulation of CTL proliferation after infection with LCMV
(Fig. 6).
We have shown above that ICOS was more important
for CD41 T cell responses to VSV than to LCMV infec-
tion. It remained possible that this was also the case for
CTL responses. To assess this possibility, we studied the
role of CD28 and ICOS in the generation of CTL re-
sponses to VSV. In agreement with a previous report (2),
we found that CTL responses to VSV were abrogated in
the absence of CD28 (Fig. 5 C). In contrast, inhibition of
ICOS did not significantly affect the VSV-specific CTL re-
sponse in the presence of CD28 (not shown). Due to the
profound suppression of CTL induction, it was impossible
to assess the contribution of ICOS in the absence of CD28.
Nevertheless, these data further indicate that ICOS plays a
minor role in costimulation of CTL responses.
Figure 4. Blocking ICOS does
not affect antibody isotype switch-
ing after infection with LCMV.
CD282/2 mice and C57BL/6 con-
trol mice (BL6) were infected with
200 PFU LCMV) and treated with
ICOS-Ig or control IgG1 (solid
bars) starting at day 0 every 2 d until
day 10. Blood was taken 12 d after
infection, and LCMV-specific IgG1,
IgG2a, and IgG2b titers were deter-
mined by ELISA. Data are represen-
tative of two separate experiments.
Figure 5. Blocking ICOS does not affect antiviral CTL responses.
CD282/2 mice (open symbols) and C57BL/6 control mice (BL/6, filled
symbols) were infected with LCMV (200 PFU) into the footpad (A and
B) or with VSV intravenously (C). Groups of mice were injected intra-
peritoneally with ICOS-Ig (circles) or control IgG1 (squares) starting at day
0 every 2 d until day 10 (A and B) or until day 4 (C). (A) CD81 T cell–
mediated footpad swelling was assessed daily with a spring-loaded caliper.
(B) LCMV-specific CTL activity was assessed 12 d after infection in a
51Cr-release assay on peptide-pulsed target cells. (C) VSV-specific CTL
activity was assessed 6 d after infection in a 51Cr-release assay on peptide-
pulsed target cells. Data are representative of two separate experiments.58 Role of ICOS and CD28 in Response to Pathogens
Discussion
This study addressed the role of ICOS-mediated T cell
costimulation in the presence and absence of CD28 in
vivo. Our results suggest that ICOS plays a minor role, if
any, in the regulation of CTL responses but contributes to
the generation of Th1 and Th2 cell responses, in particular
in the absence of CD28.
Human ICOS has been observed to stimulate the pro-
duction of IFN-g (Th1) and IL-10 (Th2) in vitro upon
cross-linking (10). Consistent with this finding, inhibition
of ICOS during infection with the nematode N. brasiliensis
resulted in reduced ex vivo Th1 and Th2 cytokine produc-
tion upon restimulation with N. brasiliensis antigens. Visual-
ization of T cells and their cytokine patterns infiltrating the
lungs in response to N. brasiliensis infection showed that
frequencies of both lung Th1 and Th2 cells were reduced
in the absence of CD28. Blocking of ICOS in CD28-defi-
cient mice showed a further reduction, whereas ICOS in-
hibition in the presence of CD28 played a limited role.
Remarkably, CD28 and ICOS costimulation did not dif-
ferentially regulate Th subset development. Parasite-induced
Th2 but also Th1 cell development was affected in the ab-
sence of either costimulatory pathway. Moreover, inhibi-
tion of ICOS attenuated VSV-specific Th1 responses in the
presence of CD28 and LCMV-specific Th1 responses in
the absence of CD28. Expulsion of N. brasiliensis is criti-
cally dependent on Th2 responses mediated by the IL-4R–
signal transducer and activator of transcription 6 (STAT6)
pathway (16–18). Remarkably, we found that CD28-defi-
cient mice treated with ICOS-Ig expelled worms normally
by day 13 (not shown), despite a massive inhibition of Th2
development (Fig. 2). This successful expulsion in the ab-
sence of effective Th2 responses may be the consequence
of similarly impaired Th1 responses, which inhibit worm
expulsion (15).
Triggering of CD28 has been suggested to be required
for Th2 rather than for Th1 responses in vitro (23) and in
vivo (24–26). Similarly, we recently found that inhibition
of ICOS reduced Th2- but not Th1-dependent lung in-
flammation and airway hyperresponsiveness (Coyle, A.J.,
and J.-C. Gutierrez-Ramos, manuscript submitted for pub-
lication). It is important to note that this selective inhibi-
tion of Th2 responses by blocking of ICOS was observed
after adoptive transfer of in vitro–polarized Th1 versus Th2
effector cells and intranasal aeroallergen challenge. In con-
trast, in the experiments presented here, Th subset differen-
tiation was inhibited de novo, since mice were treated with
ICOS-Ig before and during pathogen infection. Therefore,
it is possible that shortly after T cell activation ICOS is ex-
pressed on both Th1 and Th2 precursor populations,
whereas a Th2-specific expression of ICOS and hence a
discrete regulatory function is only apparent on highly po-
larized effector Th2 cells.
The importance of ICOS-mediated costimulation in the
presence of CD28 seems to vary with the antigen. Al-
though blocking ICOS in the presence of CD28 had no
measurable effect on LCMV-specific Th1 responses, it re-
duced VSV-specific Th1 responses. Similarly, Th1 re-
sponses to VSV compared with LCMV were more strongly
dependent on the presence of CD28. This may suggest that
“weak” T cell responses (e.g., VSV) depend to a relatively
high degree on CD28 and ICOS signaling, with partial
functional overlap of the two pathways, whereas “strong”
T cell responses (e.g., LCMV) depend partially on CD28
(Fig. 3 A) and OX40 (9), with no or little contribution of
the ICOS pathway. As pointed out previously, the dura-
tion of antigenic stimulation may be a critical factor for the
costimulatory dependence of the various antigens (2).
ICOS is expressed at high levels on germinal center T
cells (10). In addition, as shown here, ICOS mediates resid-
ual Th cell responses in CD282/2 mice. It was therefore
surprising that reduced CD41 T cell proliferation and Th
subset differentiation in ICOS-Ig–treated CD282/2 mice
did not diminish specific antibody responses to LCMV be-
low levels in CD282/2 mice. Even in the absence of
CD28, when proliferation was reduced by z85%, there
was still a considerably strong LCMV-specific IgG re-
sponse, although it was reduced 5–10-fold compared with
wild-type mice. Recently, we reported that OX402/2
mice show normal B cell responses despite impaired ex
vivo proliferation and differentiation after virus infection
(9). These examples demonstrate that impaired CD41 pro-
liferation ex vivo does not necessarily translate into reduced
T help available for B cells in vivo. Distinct populations of
T cells may mediate in vitro proliferative responses and in
vivo isotype switching. Alternatively, it may be particularly
difficult to neutralize ICOS on germinal center T cells,
which express ICOS at very high levels. Nevertheless, after
immunization with protein antigen (OVA) in alum, spe-
cific antibody response (e.g., IgG1, IgG2a, and IgE) levels
were inhibited by ICOS-Ig treatment, in particular in a
secondary immune response (Coyle, A.J., and J.-C. Gutier-
rez-Ramos, manuscript submitted for publication). Like-
Figure 6. Blocking ICOS does not affect frequencies of LCMV-spe-
cific CTLs. CD282/2 mice (right) and C57BL/6 control mice (left) were
infected with LCMV and treated with ICOS-Ig or control IgG1. Spleen
cells were isolated 12 d after infection, and specific T cells were stained
using H-2Db tetramers pulsed with peptide p33.59 Kopf et al.
wise, although CTLA-4-Ig is effective in inhibiting a pri-
mary immune response (27), some studies have shown that
secondary immune responses cannot be fully suppressed by
administration of CTLA-4-Ig (28), consistent with B7-
independent activation of effector and memory cells (29).
Taken together, it appears that the requirement of different
costimulatory molecules is dependent on both (a) the na-
ture of the antigen and (b) the phase of the immune re-
sponse (e.g., induction versus maintenance of primary ver-
sus memory responses).
ICOS was observed to be more important for the induc-
tion of Th cell responses than CTL responses. This finding
is compatible with the notion that CTL responses are gen-
erally less dependent on costimulatory molecules than Th
cell responses. Indeed, LCMV-specific CTL responses are
poorly affected in CD282/2 mice (Fig. 5 B; references 1,
2), whereas CD41 T cell responses against the same virus
are reduced more strikingly (Fig. 3, A and B). Similarly, al-
though maximal Th cell responses have been observed to
depend on functional CD40–CD40L and OX40–OX40L
interactions, the corresponding primary CTL responses
were induced normally in the respective gene-deficient
mice (9, 30–33). In this respect, the 4-1BB–4-1BBL inter-
action is an exception, since it is thought to affect CTL
rather than Th cell responses (34). In light of these previous
findings, it may not be surprising that ICOS-mediated co-
stimulation affected Th cell rather than CTL responses in
vivo. For immune responses, this difference for costimula-
tory requirements between CTLs and Th cells remains
speculative. It has been known for some time that tolerance
at the Th cell level is much more stringent than tolerance at
the B cell level (35, 36). This observation was explained by
the notion that optimal induction of Th cells is crucial for
B cell isotype switching. In fact, in the absence of func-
tional T cell help, antibody production remains transient
and no B cell memory is generated. Hence, strict control of
CD41 T cell responses may be sufficient to avoid B cell–
mediated autoimmunity. By analogy, CD41 T cells may
serve as critical regulators of CTL responses. Although the
CD41 T cell dependence of many CTL responses is cer-
tainly less obvious than the CD41 T cell dependence of
most B cell responses, it is nevertheless striking that (a)
weak CTL responses against, e.g., tumor antigens are de-
pendent on the presence of CD41 T cells (37–39); (b)
memory CTL responses to viruses fade away in the absence
of CD40–CD40L interaction and T cell help (31, 32); and
(c) the presence of functional Th inhibits the exhaustion
and/or peripheral deletion of CTL (40). Taken together,
CD41 T cells are involved in regulation of acute and long-
term CTL responses under some circumstances. As ob-
served previously for B cells, stringent control of Th cells
may be sufficient to avoid CD81 T cell–mediated autoim-
munity in many cases. Thus, CTLs may be less dependent
on the presence of costimulation than Th cells, since their
long-term responsiveness is controlled by the continuous
presence of specific T help.
Although we have titrated the amounts of ICOS-Ig in
vitro and in vivo using another model antigen (not
shown), we cannot entirely exclude that ICOS-L blocking
was incomplete. In our experiments, Th cell generation
was more affected by blocking of ICOS in CD28-deficient
mice than in wild-type mice. This may indicate that ICOS
does not deliver a unique signal, but may costimulate T
cell responses using signaling pathways similar to CD28.
Thus, CD28 may be able to compensate relatively well for
lack of ICOS. In contrast, ICOS seems to be able to re-
place CD28 only under certain circumstances. Specifically,
pathogens are often able to induce CD28-independent T
cell responses, whereas model antigens fail to do so (6).
The distinct expression patterns of CD28 and ICOS and
their respective ligands B7 and B7Rp (B7h) may explain
the difference (11, 41). The relatively broad tissue distribu-
tion of ICOS ligand(s) and the upregulation in nonlym-
phoid compartments in an inflammatory setting suggest a
role for these new costimulators that is different from the
CD28–B7 interactions (11, 41). CD28 is constitutively ex-
pressed on T cells, whereas ICOS is only expressed on ac-
tivated T cells (10). Consequently, ICOS cannot initiate a
T cell response. Pathogens usually stimulate T cells for ex-
tended time periods, which has been shown to be critical
for their ability to induce T cell responses in the absence of
CD28 (2). Moreover, pathogens often activate APCs via
innate mechanisms, further increasing T cell stimulation by
APCs (2, 5). This extensive and long-lived TCR trigger-
ing may be able to activate T cells sufficiently for the ex-
pression of alternative costimulatory molecules such as
ICOS. By contrast, model antigens may often fail to acti-
vate T cells sufficiently for ICOS expression in the absence
of CD28. Consequently, these types of antigens depend to
a higher degree on the presence of CD28 for T cell prim-
ing. In this respect, CD28 and ICOS may behave similarly
to CD40 and receptor activator of nuclear factor kB
(RANK). Only pathogens, but not proteins in adjuvants,
were found to stimulate APCs and Th cell responses via
the RANK pathway in the absence of CD40 (42). CD28
and CD40 are expressed constitutively, whereas ICOS (10)
and RANK ligand (43) are expressed only after cell activa-
tion. Hence, neither ICOS nor RANK ligand can initiate
T cell responses. However, they can sustain T cell re-
sponses that have been initiated by a costimulation-inde-
pendent mechanism.
Thus, this study demonstrates that ICOS costimulates
both Th1 and Th2 responses to various pathogens. Al-
though CD28 appears to be more essential than ICOS,
both pathways are partially overlapping and ICOS may pri-
marily stimulate T cells in the absence of CD28–B7 inter-
actions.
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